Zhaoke Ophthalmology
Manufacturing · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Hong Kong, Central and Western, ChinaWebsite
www.zkoph.comRevenue
$18.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Zhaoke Ophthalmology
兆科眼科, established in 2017 and listed on the Hong Kong Stock Exchange in 2021, is a leading ophthalmic pharmaceutical company focused on the research, production, and commercialization of ophthalmic therapies to address significant global healthcare needs. The company has developed a pipeline of candidate drugs, including innovative and generic medications targeting six major ophthalmic indications, manufactured at its advanced facility in Nansha, Guangzhou. With an ambitious growth strategy and collaborations with domestic and international pharmaceutical companies, 兆科眼科 aims to become a global leader in ophthalmology. The company is dedicated to improving vision health for the general public in China through scientific advancements.Explore more
Zhaoke Ophthalmology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zhaoke Ophthalmology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Zhaoke Ophthalmology
Earning: See what the market has to say on Zhaoke Ophthalmology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Zhaoke Ophthalmology has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Zhaoke Ophthalmology had a recent Job posting/layoffs
Product Launch: Get notified when Zhaoke Ophthalmology launches new products
Check out if Zhaoke Ophthalmology is spiking on competitors!
Zhaoke Ophthalmology, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Zhaoke Ophthalmology has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Zhaoke Ophthalmology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zhaoke Ophthalmology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zhaoke Ophthalmology.
Zhaoke Ophthalmology Tech Stack
A closer look at the technologies used by Zhaoke Ophthalmology
Zhaoke Ophthalmology News & Media
Zhaoke Ophthalmology Enters Into Exclusive Agreement With Eyedetec Medical - Vision Monday
DANVILLE, Calif.—Zhaoke Ophthalmology Limited, a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address unmet medical needs, has entered into an exclusive license, supply and distribution agreement with Eyedetec Medical, Inc., a leading U.S.-based company specializing in medical devices for the treatment of dry eye disease and meibomian gland dysfunction.Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer™ for the Treatment of Dry Eye Disease
DANVILLE, Calif., June 8, 2023 /PRNewswire/ -- Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company", SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address...Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
HONG KONG, Oct 28, 2022 - (ACN Newswire) - Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or "the Company", SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research, development, manufacturing and commercialization of treatments that address significant unmet medical needs, is pleased to announce that the Company's partner Vyluma, Inc. ("Vyluma") , a biopharmaceutical company developing multiple assets for the treatment of refractive errors, announced top-line resZhaoke Ophthalmology Announces 2022 Interim Results
HONG KONG, Aug 24, 2022 - (ACN Newswire) - Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company", SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet medical needs, today announced its interim results for the six months ended 30 June 2022 ("Reporting Period"). Zhaoke Ophthalmology is strategically focused on treatments that cover a wide range of ophthalm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zhaoke Ophthalmology
Sign Up For FreeTo access detailed company insights
兆科眼科, established in 2017 and listed on the Hong Kong Stock Exchange in 2021, is a leading ophthalmic pharmaceutical company focused on the research, production, and commercialization of ophthalmic therapies to address significant global healthcare needs. The company has developed a pipeline of candidate drugs, including innovative and generic medi... Read More
